Form 8-K Medicus Pharma Ltd. For: Dec 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Medicus Pharma establishes $15.3 million at-the-market equity program
December 30, 2025 9:29 AM ESTMedicus Pharma Ltd. (NASDAQ: MDCX) entered into an equity distribution agreement on December 29, 2025, with Maxim Group LLC and Yorkville Securities LLC to establish an at-the-market equity program worth up to $15,349,674.
Under the agreement, the company may sell common shares from... More
